期刊文献+

人重组pEGFPC1-uPA ATF质粒的构建及表达的研究

Construction and expression of recombinant eukaryotic expression vector pEGFPC1-uPA ATF
下载PDF
导出
摘要 目的构建含人uPA ATF基因的真核表达质粒,并研究其对小鼠细胞株Pam212细胞的影响。方法设计引物,利用PCR从原核表达质粒中扩增人uPA ATF基因片断,并导入真核表达载体的绿色荧光蛋白pEGFPC1中,利用电泳和测序检测构建状况,荧光显微镜观察和免疫细胞化学检测转染情况,通过MTT、体外迁移实验检测对小鼠Pam212细胞株的影响。结果电泳和测序表明构建的质粒准确,uPA ATF cDNA阅读框完整,连接部位序列正确;质粒转染Pam212细胞株成功,并且能抑制细胞的增殖和迁移。结论成功构建了真核表达载体pEGFPC1-uPA ATF质粒,明确了人uPA ATF基因片断能降低小鼠细胞的增殖和迁移,为进一步在体实验研究打下了基础。 Objective To construct eukaryotic expression plasmid of pEGFPCI-uPA ATF gone, and investigate the effect of the plasmid on proliferation and migration of mouse Pam 212 cells. Methods Human uPA ATF cDNA was cloned from the prokaryotic plasmid by PCR technique, and then inserted into the eukaryotic expression plasmid pEGFPC1. The reconstructed plasmid was transfected into Pam 212 cells, and then identified by fluorescent microscopy and immunocytochemistry. Proliferation and the migration of the transfected cells were explored. Retmlts The reconstructed plasmid of pEGFPCI-uPA ATF was confirmed by the sequence analysis. The reconstructed plasmid could reduce the proliferation and migration ability of Pare 212 cells. Conclusion The pEGFPCI-uPA ATF plasmid is constructed successfully, uPA ATF can reduce the growth and invasion of Pam 212 cells, which lay a foundation for further studies of uPA ATF in vivo.
出处 《免疫学杂志》 CAS CSCD 北大核心 2007年第1期80-83,共4页 Immunological Journal
基金 国家自然科学基金资助项目(30270670 30371383)
关键词 UPA ATF pGFPC1 PAM 212细胞 uPA ATF pGFPC1 Pam 212 cells
  • 相关文献

参考文献14

  • 1Kim KS,Hong YK,Lee Y,et al.Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains:amino-terminal fragment and kringle domain[J].Exp Mol Med.2003,35(6):578-585.
  • 2Mukhina S,Stepanova V,Traktouev D,et al.The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain.Characterization of interactions and contribution to chemotaxis[J].J Biol Chem,2000,275(22):16 450-16 458.
  • 3Kim KS,Hong YK,Joe YA,et al.Anti-angiogenic activity of the recombinant kringle domain of urokinase and its specific entry into endothelial cells[J].J Biol Chem,2003,278(13):11 449-l1 456.
  • 4Blasi F,Vassalli JD,Dano K.Urokinase-type plasminogen activator:proenzyme,receptor,and inhibitors[J].J Cel Biol,1987,104(4):801-804.
  • 5Belin D,Vassalli JD,Combepine C,et al.Cloning,nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator[J].Eur J Biochem,1985,148(2):225-232.
  • 6于津浦,张斌,任秀宝.人重组pMAGE-A1/EGFP真核表达质粒的构建与表达[J].免疫学杂志,2005,21(2):107-110. 被引量:1
  • 7Duffy MJ.The urokinase plasminogen activator system:role in malignancy[J].Curr Pharm Des,2004,10(1):39-49.
  • 8郝好杰,李琦,司艺玲,赵亚力,谷志远.血小板因子4对人肺巨细胞癌细胞系尿激酶和其受体表达的影响[J].免疫学杂志,2002,18(1):51-53. 被引量:1
  • 9Lefesvre P,Attema J,van Bekkum D.Adenoviral gene transfer of angiostatic ATF-BPTI inhibits tumour growth[J].BMC Cancer,2002,2:17.
  • 10朱甫祥,高临路,邢桂春,贺福初.尿激酶氨基末端基因转移对人肺癌细胞系PG转移性的抑制作用[J].中华医学杂志,2000,80(10):797-798. 被引量:1

二级参考文献7

  • 1Xing R H,Int J Cancer,1996年,67卷,423页
  • 2金冬雁 黎孟枫 侯云德 译.分子克隆实验指南[M]:2版[M].北京:科学出版社,1999.16-22.
  • 3Thompson JD, Gibson TJ, Plewniak F, et al. The Clustal-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools [J]. Nucleic Acids Res, 1997, 25 (24): 4 876-4 882.
  • 4Imai Y, Shichijo S, Yamada A, et al. Sequence analysis of the MAGE gene family encoding human tumor-rejection antigens [J]. Gene, 1995, 160 (2): 287-290.
  • 5Hennecke M, Kwissa M, Metzger K, et al. Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs [J]. Nucleic Acids Res, 2001,29 (16): 3 327 - 3 334.
  • 6Graft Dubois S, Faure O, Gross DA, et al. Generation of CTL recognizing an HLA-A * 0201-restricted epitope shared by MAGE-A1, -A.2, -A3, -A4, -A6, -A10, and -A12 rumor antigens: implication in a broad-spetrum tumor immunotherapy [J]. J Immunol, 2002, 169 (1): 575- 580.
  • 7郝好杰,谷志远,刘文英,宋海静,赵亚力,李琦.血小板因子4基因转染对肺癌细胞中血管生成因子基因表达的影响[J].中国免疫学杂志,2001,17(5):256-258. 被引量:2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部